Table 1. Summary of cell line specific features that were taken in consideration for this study.
| Cell line name | Tissue | Disease | Karyotype* | Optimal frequency (kHz) | Doubling time (hours) |
|---|---|---|---|---|---|
| A2780 | Ovary | Carcinoma | Modal chromosome number = 46 | 200 | 18.7 |
| A549 | Lung | Adenocarcinoma | Hypotriploid, modal chromosome number = 66 in 24% of cells | 150 | 23.8 |
| AsPC-1 | Pancreas | Adenocarcinoma | Not specified | 150 | 54.0 |
| HeLa | Cervix | Adenocarcinoma | Modal number = 82; range = 70 to 164 | 150 | 24 |
| MCF-7 | Mammary gland; breast | Adenocarcinoma | Hypertriploidy to hypotetraploidy, modal chromosome number = 82 | 150 | 29.3 |
| MDA-MB-231 | Mammary gland: breast | Adenocarcinoma | Near-triploid, modal number = 64 | 150 | 29.1 |
| MSTO- 211H | Lung | Biphasic mesothelioma | Modal chromosome number = 72 | 150 | 26.4 |
| NCI-H1299 | Lung | Carcinoma; NSCLC | Not specified | 150 | 23.1 |
| NCI-H2052 | Lung | Stage 4, mesothelioma | Not specified | 200 | 18.9 |
| U-87 MG | Brain | Grade IV glioblastoma; astrocytoma | Hypodiploid, modal chromosome number = 44 in 48% of cells | 200 | 34.0 |
| U-118 MG | Brain | Grade IV glioblastoma; astrocytoma | Hypodiploid, modal chromosome number = 44 in 48% of cells | 200 | 18.5 |
*According to ATCC and/or NCI SKY/M-FISH & CGH Database.